Feed excerpt — reported by The Guardian
Exclusive: investigation finds prescriptions for children under 12, as experts stress need for specialist supervision and long-term monitoringHundreds of children in England are receiving prescriptions for GLP-1 medications, including some younger than 12, the Guardian can reveal.GLP-1 medications were initially developed to help people with type 2 diabetes control their blood sugar levels, but have since become a popular slimming aid, with products such as Wegovy and Mounjaro becoming household names. Continue reading…
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at The Guardian →